Thrombotic risk factors | Warfarin pharmacogenetics | ||||||
---|---|---|---|---|---|---|---|
F5 | F2 | MTHFR | CYP2C9 | VKORC1 | |||
N (%) | 1691G>A | 20210G>A | 677C>T | 1298A>C | 430C>T | 1075A>C | 1639G>A |
1 (1.7) | G A | GG | TT | AA | TT | A C | G A |
1 (1.7) | G A | GG | TT | AA | C T | A C | AA |
1 (1.7) | GA | GG | CC | AC | CT | AC | GA |
2 (3.5) | GA | GG | CT | AA | CT | AC | GA |
1 (1.7) | GA | GG | CC | AC | CT | AC | GG |
1 (1.7) | GG | GA | CT | AC | CC | AC | AA |
1 (1.7) | GA | GG | CC | CC | CC | AC | GA |
1 (1.7) | GA | GG | CT | AC | CC | AC | GA |
1 (1.7) | GG | G A | TT | AA | CC | A C | G A |
1 (1.7) | GA | GG | CC | AC | CC | AC | GG |
2 (3.5) | GA | GG | CT | AA | CC | AC | GG |
1 (1.7) | G A | GG | TT | CC | TT | AA | G A |
1 (1.7) | GA | GG | CT | AA | CT | AA | AA |
1 (1.7) | GA | GG | CT | AC | CT | AA | GA |
1 (1.7) | G A | GG | TT | AA | C T | AA | G A |
2 (3.5) | GG | GA | CT | AC | CT | AA | GA |
1 (1.7) | GG | GA | CT | AA | CT | AA | GG |
2 (3.5) | GA | GG | CT | AA | CT | AA | GG |
1 (1.7) | G A | GG | TT | AA | C T | AA | GG |
2 (3.5) | GA | GG | CC | AC | CC | AA | AA |
1 (1.7) | GA | GG | CT | AA | CC | AA | AA |
3 (5.2) | G A | GG | TT | AA | CC | AA | AA |
1 (1.7) | GG | GA | CC | AC | CC | AA | AA |
1 (1.7) | GG | GA | CT | AC | CC | AA | AA |
1 (1.7) | GG | G A | TT | AA | CC | AA | AA |
2 (3.5) | GA | GG | CC | AC | CC | AA | GA |
1 (1.7) | GA | GG | CT | AA | CC | AA | GA |
2 (3.5) | GA | GG | CT | AC | CC | AA | GA |
4 (6.9) | G A | GG | TT | AA | CC | AA | G A |
1 (1.7) | GG | AA | CC | AC | CC | AA | GA |
1 (1.7) | GG | GA | CC | AC | CC | AA | GA |
1 (1.7) | GG | GA | CC | CC | CC | AA | GA |
2 (3.5) | GG | GA | CT | AA | CC | AA | GA |
2 (3.5) | GA | GG | CC | AC | CC | AA | GG |
3 (5.2) | GA | GG | CT | AA | CC | AA | GG |
2 (3.5) | GA | GG | CT | AC | CC | AA | GG |
1 (1.7) | GG | GA | CC | CC | CC | AA | GG |
1 (1.7) | GG | GA | CT | AA | CC | AA | GG |
3 (5.2) | G A | GG | TT | AA | CC | AA | GG |